Second Dose of Palonosetron Reduces CINV in Pediatric Cancer Patients

An additional dose of palonosetron can help prevent chemotherapy-induced nausea and vomiting (CINV) in children with cancer who are receiving multiple-day moderately or highly emetogenic chemotherapy, a randomized study suggests.

Read more: https://www.cancertherapyadvisor.com/home/cancer-topics/pediatric-cancer/palonosetron-cinv-pediatric-cancer/